Table 4. Mean retinal thicknesses (μm) measured by OCT at 1, 2, and 3 months after eye drop administration.
| Time | Layer |
Mino-OD | Mino-OS |
NT group | Control group |
|||
|---|---|---|---|---|---|---|---|---|
| 1 m | Whole layer | 206.63±9.84 | 205.90±9.89 | 204.45±7.95 | 211.93±18.12 | |||
| GCIPL | 77.83±6.72 | 75.29±6.35 | 74.94±6.45 | 82.70±6.08 | ||||
| n=8 | n=8 | n=9 | n=10 | |||||
| 2 m | Whole layer | 203.94±8.75 | 202.67±10.33 | 202.56±7.08 | 209.23±17.57 | |||
| GCIPL | 76.57±7.24 | 74.07±5.85 | 73.88±7.24 | 82.72±5.76 | ||||
| n=6 | n=7 | n=5 | n=10 | |||||
| 3 m |
Whole layer | 203.39±10.72 | 201.42±9.83 | 199.24±10.75 | 212.55±17.54 | |||
| GCIPL | 75.83±6.37 | 72.42±5.99 | 71.47±5.10 | 81.92±5.64 | ||||
| n=3 |
n=4 | n=4 |
n=10 | |||||
GCIPL, ganglion cell inner plexiform layer (distance from internal limiting membrane to inner plexiform layer); n, number of animals per group at each time point.